“…Since its first description by Stern and colleagues in 1985, 23 numerous studies have suggested various explanations. Changes in distal arterial elasticity, 29 aging with a reduction in leg postjunctional alpha-adrenoceptor responsiveness to endogenous noradrenaline, 30 lower hematocrit level, 7 lower minimal body temperature, 8 CPB and clamping times, 1 , 2 vasoactive medication, 1 , 2 , 9 , 10 , 31 , 32 plasma catecholamine levels, 9 , 10 vascular thrombosis, 33 vascular decoupling in vasoplegia, 34 and demographic data 1 , 2 have all been described as potential risk factors. There is also a discrepancy in regard to vasoactive medication, since vasopressors and vasodilators have both been associated with the RFPG in different studies.…”